{"database":"ENA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Hemato-oncology, IDIBAPS"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA369382"],"scientific_name":["Homo sapiens"],"long_description":["Mantle Cell lymphoma (MCL) were treated with the BTK inhibitor 1mM CC-292 for 48h We used microarrays to uncover the mechanisms underlying CC-292 activity in Mantle Cell lymphoma (MCL) Overall design: Global RNA expression was done in two MCL cell lines treated in vitro with CC-292 for 48h"],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"Homo sapiens","description":"The BTK Inhibitor CC-292 shows activity in Mantle Cell Lymphoma and synergizes with Lenalidomide and NIK Inhibitors depending on NFκB mutational status","dates":{"last_updated":"2025-09-24","first_public":"2017-09-02"},"accession":"PRJNA369382","cross_references":{"GEO":["GSE94328"],"taxon":["9606"]}}